Loading...
•
Dec 28, 2019
Masimo Q4 2019 Earnings Report
Masimo's Q4 2019 earnings were reported, showing revenue growth and solid financial performance.
Key Takeaways
Masimo reported a total revenue of $247.5 million for Q4 2019, with product revenue increasing by 11.8% to $247.4 million. The company's GAAP net income per diluted share was $0.92, and non-GAAP net income per diluted share was $0.91.
Total revenue reached $247.5 million.
Product revenue increased by 11.8%.
GAAP net income per diluted share was $0.92.
Non-GAAP net income per diluted share was $0.91.
Masimo
Masimo
Forward Guidance
The Company provided the following estimates for its full-year 2020 guidance: Total revenue, including royalty and other revenue $1,035, Product revenue $1,035, Earnings per diluted share $3.64, Non-GAAP Earnings per diluted share $3.56
Positive Outlook
- Product revenue of $1.035 billion, which reflects growth of 10.5% and constant currency growth of 11.0%
- GAAP earnings per diluted share of $3.64
- Non-GAAP earnings per diluted share of $3.56
- Gross margin 67.7%
- Operating margin 24.0%
Challenges Ahead
- Estimated tax rate 19.1%
- Included in our full-year 2020 revenue guidance is approximately $4 million of year-over-year currency headwinds.
- Risks related to the integration of the acquisition of the Connected Care assets from NantHealth, Inc.
- Our dependence on Masimo SET® and Masimo rainbow SET™ products and technologies for substantially all of our revenue
- Any failure in protecting our intellectual property exposure to competitors’ assertions of intellectual property claims